Program Highlights
- Largest breast cancer conference specifically bringing together clinicians from North, Central and South America, Europe and the Middle East
- Highly interactive program built on the latest in adult learning principles
- Direct access to world-renowned faculty
- State-of-the-art updates on oncoplastic surgery
- CME-accredited
Program objectives
Upon successful completion of this activity, participants should be able to:
- Use genetic profiling tools and algorithms to assess prognostic and predictive factors of adjuvant chemotherapy, hormonal therapy, and HER2-targeted therapy and integrate these into management plans of individual patients
- Review progress and utility of advances in diagnosis and staging, including MRI, PET and pathology
- Recognize the role cancer stem cells play in the development and reoccurrence of breast cancer and identify novel strategies being developed targeting these stem cells
- Identify important growth and survival pathways for breast cancer, including steroid hormone receptors, the HER/ErbB family, IGFR, and mediators of angiogenesis, as well as the novel agents that target these pathways and apply this knowledge in clinical practice
- Evaluate key updates in adjuvant and neoadjuvant chemotherapies, endocrine therapies, systemic treatments without chemotherapy, and biologic combinations to optimize and individualize treatment for patients with breast cancer
- Relate the use of bisphosphonates for both bone health and to reduce the recurrence risk to the management of patients in defined clinical scenarios
- Learn about current and future clinical trials open for the referral of appropriate patients
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of PESI, LLC and Inter-American Breast Cancer Conference (IABCC). PESI, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Who should attend?
This international, multi-disciplinary educational activity is directed at individuals with clinical and/or research interests in the biology, prevention, epidemiology, diagnosis, and multidisciplinary treatment of breast cancer including: medical, radiation and surgical oncologists and radiologists.
The program can also benefit nurses, pharmacists, physician assistants, and all other health care professionals involved in clinical care and research in breast cancer.
Page last updated: May 30, 2011